S0012 Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Filgrastim in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Georgiana K. Ellis, MD
Seattle Cancer Care Alliance
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
314 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Mobile Infirmary Medical Center
Mobile, Alabama, United States
- Alaska Regional Hospital Cancer Center
Anchorage, Alaska, United States
- Fairbanks Cancer Treatment Center at Fairbanks Memorial Hospital
Fairbanks, Alaska, United States
- Mayo Clinic Scottsdale
Scottsdale, Arizona, United States
- Hembree Mercy Cancer Center at St. Edward Mercy Medical Center
Fort Smith, Arkansas, United States
- Arkansas Cancer Research Center at University of Arkansas for Medical Sciences
Little Rock, Arkansas, United States
- Highlands Oncology Group - Springdale
Springdale, Arkansas, United States
- Glendale Memorial Hospital Comprehensive Cancer Center
Glendale, California, United States
- Saint Rose Hospital
Hayward, California, United States
- Valley Memorial Hospital
Livermore, California, United States
- Usc/norris Comprehensive Cancer Center and Hospital
Los Angeles, California, United States
- Ccop - Bay Area Tumor Institute
Oakland, California, United States
- Highland General Hospital at St. George'S University School of Medicine
Oakland, California, United States
- Summit Medical Center
Oakland, California, United States
- Comprehensive Cancer Center at Desert Regional Medical Center
Palm Springs, California, United States
- J.C. Robinson, M.D. Regional Cancer Center
San Pablo, California, United States
- Memorial Hospital Cancer Center
Colorado Springs, Colorado, United States
- Halifax Medical Center
Daytona Beach, Florida, United States
- Michael & Dianne Bienes Comprehensive Cancer Center at Holy Cross Hospital
Fort Lauderdale, Florida, United States
- Memorial Cancer Institute at Memorial Regional Hospital
Hollywood, Florida, United States
- Mayo Clinic - Jacksonville
Jacksonville, Florida, United States
- Ella Milbank Foshay Cancer Center at Jupiter Medical Center
Jupiter, Florida, United States
- Ccop - Mount Sinai Medical Center
Miami Beach, Florida, United States
- Cancer Research Center of Hawaii
Honolula, Hawaii, United States
- Kapiolani Medical Center for Women and Children
Honolulu, Hawaii, United States
- Oncare Hawaii, Incorporated - Kuakini
Honolulu, Hawaii, United States
- Oncare Hawaii, Incorporated - Lusitana
Honolulu, Hawaii, United States
- Queen'S Cancer Institute at Queen'S Medical Center
Honolulu, Hawaii, United States
- St. Francis Medical Center
Honolulu, Hawaii, United States
- Straub Clinic and Hospital, Incorporated
Honolulu, Hawaii, United States
- Tripler Army Medical Center
Honolulu, Hawaii, United States
- Kapiolani Medical Center at Pali Momi
‘Aiea, Hawaii, United States
- Saint Alphonsus Cancer Care Center at Saint Alphonsus Regional Medical Center
Boise, Idaho, United States
- St. Luke'S Mountain States Tumor Institute - Boise
Boise, Idaho, United States
- North Idaho Cancer Center
Coeur d'Alene, Idaho, United States
- Saint Anthony'S Hospital at Saint Anthony'S Health Center
Alton, Illinois, United States
- Rush-Copley Cancer Care Center
Aurora, Illinois, United States
- Medical and Surgical Specialists, L L C
Galesburg, Illinois, United States
- Joliet Oncology Hematology Associates, Limited - West
Joliet, Illinois, United States
- Cardinal Bernardin Cancer Center at Loyola University Medical Center
Maywood, Illinois, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 May 2001
- Primary completion
- 30 Sept 2006
- Completion
- 29 Feb 2012
- Last update posted
- 24 Jan 2013
- Registered enrollment
- 399
- Registry id
- NCT00016406
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.